Expression of CD44 in kidney following acute ischemic injury in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 1 47-1, 2000, Pages

  Lewington, Andrew J P ^a   Padanilam, Babu J ^a   Martin, Daniel R ^a   Hammerman, Marc R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute renal failure; Arginine glycine aspartate peptides; Hyaluronic acid; Matrix; Osteopontin

Indexed keywords

CD44V ANTIGEN; HYALURONIC ACID; LIGAND; OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0034085930     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.1.r247     Document Type: Article

References (26)

1. Basile, D. P., J. M. Rovak, D. R. Martin, and M. R. Hammerman. Increased transforming growth factor-1 expression in regenerating rat renal tubules following ischemic injury. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 270: F500-F509, 1996.
2. Borland, G., J. A. Ross, and K. Guy. Forms and functions of CD44. Immunology 93: 139-148, 1998.
3. Franklin, S. C., M. G. Moulton, G. A. Sicard, M. R. Hammerman and S. B. Miller. Insulin-like growth factor I preserves renal function postoperatively. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 272: F257-F259, 1997.
4. Girard, N., A. Delpech, and B. Delpech. Characterization of hyaluronic acid on tissue sections with hyalurectin. Histochem. Cytochem. 34: 539-541, 1986.
5. Jain, M., H. Qi, W. Lee, S. Kashiki, L. C Foster, J. Tsai, M. Lee, and E. Haber. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J. Clin. Invest. 97: 596-603, 1996.
6. Jun, Z., P. A. Hill, H. Y. Lan, R. Foti, W. Mu, R. C. Atkins, and D. J. Nikolic-Paterson. CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin. Exp. Immunol. 108: 69-77, 1997.
7. Kleinman, J. G., E. M. Worchester, A. M. Beshensky, A. M. Sheridan, J. V. Bonventre, and D. Brown. Upregulation of osteopontin expression by ischemia in rat kidney. Ann. NY Acad. Sci. 760: 321-323, 1995.
8. Liaw, L., D. E. Birk, C. B. Ballas, J. S. Whitsett, J. M. Davidson, and B. L. M. Hogan. Altered would healing in mice lacking a functional osteopontin gene. J. Clin. Invest. 101: 1468-1478, 1998.
9. Mackay, C. R., H. J. Terpe, R. Stauder, W. L. Marston, H. Stark, and U. Günthert. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124: 71-82, 1994.
10. Miller, S. B., D. R. Martin, J. Kissane, and M. R. Hammerman. Rat models for clinical use of insulin-like growth factor I in acute renal failure. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 266: F949-F956, 1994.
11. Naor, D., R. V. Sionov, and D. Ish-Shalom. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71: 241-319, 1997.
12. Nikolic-Paterson, D. J., Z. Jun, G. H. Tesch, H. Y. Lan, R. Foti, and R. C. Atkins. De novo CD44 expression by proliferating mesangial cells in rat anti-thy-1 nephritis. J. Am. Soc. Nephrol. 7: 1006-1014, 1996.
13. Noiri, E., K. Dickman, F. Miller, G. Romanov, V. Romanov, R. Shaw, A. F. Chambers, S. R. Rittling, D. T. Denhardt, and M. S. Goligorsky. Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. Kidney Int. 56: 74-82, 1999.
14. Noiri, E., J. Gailit, D. Sheth, H. Magazine, M. Gurrath, G. Muller, H. Kessler, and M. S. Goligorsky. Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney Int. 46: 1050-1058, 1994.
15. Oksala, O., T. Salo, R. Tammi, L. Häkkinen, M. Jalkanen, P. Inki, and H. Larjava. Expression of proteoglycans and hyaluronan during wound healing. J. Histochem. Cytochem. 43: 125-135, 1995.
16. Padanilam, B. J., D. R. Martin, and M. R. Hammerman. Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology 137: 2133-2140, 1996.
17. Rodan, G. A. Osteopontin overview. Ann. NY Acad. Sci. 760: 1-5, 1995.
18. Romanov, V., E. Noiri, G. Czerwinski, D. Finsinger, H. Kesseler, and M. S. Goligorsky. Two novel probes reveal tubular and vascular Arg-Gly-Asp (RGD) binding sites in the ischemic rat kidney. Kidney Int. 52: 93-102, 1997.
19. Sibalic, V., X. Fan, J. Loffing, and R. P. Wuthrich. Upregulated CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Nephrol. Dial. Transplant. 12: 1344-1353, 1997.
20. Singh, K., A. B. Mukherjee, M. W. DeVogue, and B. B. Mukherjee. Differential processing of osteopontin transcripts in rat kidney and osteoblast-derived cell lines. J. Biol. Chem. 267: 23847-23851, 1992.
21. Terpe, H. J., H. Stark, P. Prehm, and U. Günthert. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 101: 79-89, 1994.
22. Terpe, H. J., S. Störkel, U. Zimmer, V. Anquez, C. Fischer, K. Pantel, and U. Günthert. Expression of CD44 isoforms in renal cell tumors. Am. J. Pathol. 148: 453-463, 1996.
23. Toback, F. G. Regeneration after acute tubular necrosis. Kidney Int. 41: 226-246, 1992.
24. Weber, G. F., S. Ashkar, and H. Cantor. Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc. Assoc. Am. Physicians 109: 1-9, 1997.
25. Weber, G. F., S. Ashkar, M. J. Glimcher, and H. Cantor. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512, 1996.
26. Wirth, K., R. Arch, C. Somasundaram, M. Hofmann, B. Weber, P. Herrlich, S. Matzku and M. Zoller. Expression of CD44 isoform carrying metastasis-associated sequences in newborn and adult rats. Eur. J. Cancer 29: 1172-1177, 1993.